South Korea Metered Dose Inhalers Market Size, Share, and Future Opportunities by 2035

Managing chronic obstructive pulmonary disease (COPD) and asthma in South Korea involves tailored therapeutic protocols that rely heavily on pressurized metered-dose inhalers (pMDIs). As highlighted in recent findings on the South Korea Metered Dose Inhalers Industry Trends, the market encompasses a broad range of pharmacological agents, extending from single-agent rescue treatments to complex fixed-dose combination therapies designed for long-term disease stabilization.

Key Pharmacological Classes Delivered via pMDI

The South Korean pMDI landscape includes several core therapeutic drug classes:

• Short-Acting Beta2-Agonists (SABAs): Medications like salbutamol are widely used as first-line rescue therapies for acute bronchospasms.

• Inhaled Corticosteroids (ICS): Essential anti-inflammatory agents prescribed to control persistent airway inflammation in asthmatic patients.

• Long-Acting Muscarinic Antagonists (LAMAs) & LABAs: Primary bronchodilators utilized for maintenance treatment in moderate-to-severe COPD cases.

The Shift Toward Triple Combination Therapies

To streamline treatment protocols and enhance medication compliance, South Korean pulmonologists are increasingly prescribing single-inhaler triple therapies (ICS/LAMA/LABA). Combining three active ingredients into a single pMDI canister allows for simultaneous reduction of inflammation and maximum bronchodilation. Clinical evidence in South Korea indicates that single-inhaler regimens significantly improve patient adherence compared to multiple separate devices, leading to better long-term lung function outcomes.

Breath-Actuated Devices and Patient-Centric Accessories

Proper inhalation technique remains a key focus for South Korean clinicians, as uncoordinated actuation often reduces drug deposition in the lower airways. To address this issue, the adoption of breath-actuated MDIs and valved holding chambers (spacers) has grown considerably across pediatric and geriatric care settings. Spacers help eliminate the need for precise coordination between device actuation and inhalation, ensuring that elderly patients receive the full therapeutic dose while minimizing local side effects such as oral candidiasis.